Showing results (1-10 of 176) with videos related to
Sort By:
Pageof 18
Precision Clinical Medicine|December 25, 2025
Obesity care in Chinese adults: from evidence to clinical practiceJing An, Qingyi Jia, Yan Huang, et al.Chinese Medical Journal|May 16, 2025
Incidence, prevalence, and burden of type 2 diabetes in China: Trend and projection from 1990 to 2050Haojie Zhang, Qingyi Jia, Peige Song, et al.Cancer Management and Research|June 7, 2018
Incidental thyroid carcinoma in surgery-treated hyperthyroid patients with Graves' disease: a systematic review and meta-analysis of cohort studiesQingyi Jia, Xiaodan Li, Ying Liu, et al.Minerva Medica|December 6, 2024
Type 2 diabetes, heart failure and the treatment of their comorbiditySi Wang, Sheyu LiFrontiers in Medicine|August 14, 2023
Professional medical education approaches: mobilizing evidence for cliniciansXiafei Lyu, Sheyu LiCell Reports. Medicine|May 2, 2022
LEAP2: Next game-changer of pharmacotherapy for overweight and obesity?Dan Liu, Sheyu LiHealthcare (Basel, Switzerland)|December 17, 2024
Approaches to Reach Trustworthy Patient Education: A Narrative ReviewXiafei Lyu, Jing Li, Sheyu LiEpidemiology (Cambridge, Mass.)|January 30, 2023
Partial Identification of Personalized Treatment Response with Trial-reported Analyses of Binary SubgroupsSheyu Li, Valentyn Litvin, Charles F ManskiInternational Journal of Molecular Medicine|March 15, 2017
Glucagon-like peptide 1 receptor agonist ameliorates the insulin resistance function of islet β cells via the activation of PDX-1/JAK signaling transduction in C57/BL6 mice with high-fat diet-induced diabetesTao Hao, Hongtao Zhang, Sheyu Li, et al.Lipids in Health and Disease|May 12, 2018
Relations of lipid parameters, other variables with carotid intima-media thickness and plaque in the general Chinese adults: an observational studyQingtao Hou, Sheyu Li, Yun Gao, et al.Pageof 18